BlackRock Group’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,780,313
Closed -$591M 2977
2014
Q4
$591M Buy
2,780,313
+111,907
+4% +$22.3M 0.32% 70
2014
Q3
$475M Buy
2,668,406
+157,235
+6% +$26.1M 0.28% 76
2014
Q2
$425M Sell
2,511,171
-69,878
-3% -$10.9M 0.24% 94
2014
Q1
$320M Buy
2,581,049
+259,646
+11% +$31.6M 0.2% 112
2013
Q4
$258M Sell
2,321,403
-325,804
-12% -$31.1M 0.17% 135
2013
Q3
$239M Sell
2,647,207
-8,167
-0.3% -$733K 0.16% 142
2013
Q2
$224M Buy
+2,655,374
New +$275M 0.17% 141

Other funds holding AGN

BlackRock Group's AGN Position: Q1 2015 in Review

BlackRock Group sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 2,780,313 shares — an estimated $591M sold.

BlackRock Group first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $591M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • BlackRock Group reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • BlackRock Group sold 2,780,313 Allergan Inc shares in Q1 2015, an estimated $591M.
  • BlackRock Group first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • BlackRock Group's Allergan Inc position peaked at $591M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on BlackRock Group's 13F filing for Q1 2015, filed 13 May 2015.